OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)

Anders Korshoej; Slavka Lukacova; Jens Christian Sorensen; Frederik Lundgaard Hansen; Nikola Mikic; Axel Thielscher; Soren Ole Stigaard Cortnum; Trine Lignell Guldberg; Yasmin Ramshad-Lassen; Christian Rahbek; Kare Eg Severinsen; Gorm von Oettingen

OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)

Anders Korshoej, Slavka Lukacova, Jens Christian Sorensen, Frederik Lundgaard Hansen, Nikola Mikic, Axel Thielscher, Soren Ole Stigaard Cortnum, Trine Lignell Guldberg, Yasmin Ramshad-Lassen, Christian Rahbek, Kare Eg Severinsen, Gorm von Oettingen

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Neuro-Oncology
Volume	20
Pages (from-to)	21-21
Number of pages	1
ISSN	1522-8517
Publication status	Published - Nov 2018
Externally published	Yes
Event	23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference - New Orleans, Lao People's Democratic Republic Duration: 14 Nov 2018 → 18 Nov 2018

Conference

Conference	23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference
Country/Territory	Lao People's Democratic Republic
City	New Orleans
Period	14/11/2018 → 18/11/2018

Cite this

Korshoej, A., Lukacova, S., Sorensen, J. C., Hansen, F. L., Mikic, N., Thielscher, A., Cortnum, S. O. S., Guldberg, T. L., Ramshad-Lassen, Y., Rahbek, C., Severinsen, K. E., & von Oettingen, G. (2018). OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1). Neuro-Oncology, 20, 21-21.

@article{64fde8e87656486b838bfb8e8b9de833,

title = "OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)",

author = "Anders Korshoej and Slavka Lukacova and Sorensen, {Jens Christian} and Hansen, {Frederik Lundgaard} and Nikola Mikic and Axel Thielscher and Cortnum, {Soren Ole Stigaard} and Guldberg, {Trine Lignell} and Yasmin Ramshad-Lassen and Christian Rahbek and Severinsen, {Kare Eg} and {von Oettingen}, Gorm",

year = "2018",

month = nov,

language = "English",

volume = "20",

pages = "21--21",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

note = "23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference ; Conference date: 14-11-2018 Through 18-11-2018",

}

Korshoej, A, Lukacova, S, Sorensen, JC, Hansen, FL, Mikic, N, Thielscher, A, Cortnum, SOS, Guldberg, TL, Ramshad-Lassen, Y, Rahbek, C, Severinsen, KE & von Oettingen, G 2018, 'OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)', Neuro-Oncology, vol. 20, pp. 21-21.

OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1). / Korshoej, Anders; Lukacova, Slavka; Sorensen, Jens Christian et al.
In: Neuro-Oncology, Vol. 20, 11.2018, p. 21-21.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - OPEN-LABEL PHASE 1 CLINICAL TRIAL TESTING PERSONALIZED AND TARGETED SKULL REMODELING SURGERY TO MAXIMIZE TTFIELDS INTENSITY FOR RECURRENT GLIOBLASTOMA - INTERIM ANALYSIS AND SAFETY ASSESSMENT (OPTIMALTTF-1)

AU - Korshoej, Anders

AU - Lukacova, Slavka

AU - Sorensen, Jens Christian

AU - Hansen, Frederik Lundgaard

AU - Mikic, Nikola

AU - Thielscher, Axel

AU - Cortnum, Soren Ole Stigaard

AU - Guldberg, Trine Lignell

AU - Ramshad-Lassen, Yasmin

AU - Rahbek, Christian

AU - Severinsen, Kare Eg

AU - von Oettingen, Gorm

PY - 2018/11

Y1 - 2018/11

M3 - Conference abstract in journal

SN - 1522-8517

VL - 20

SP - 21

EP - 21

JO - Neuro-Oncology

JF - Neuro-Oncology

T2 - 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

Y2 - 14 November 2018 through 18 November 2018

ER -